Genmab — Februar 2017
-
Florian siger på Play at han i hvert fald beholder Genmab indtil slutningen af 2017. Han skal nok have positiv nyt fra øvrig pipeline, før at han ser den springe langt langt højere op.
-
fedt de har positiv skat
-
-
Legolas..Don´t go there
-
Det er også min pointe i mit indslag på Børsen Play. Rent etisk kan Genmab ikke indregne hverken godkendelse i Europa og Japan.
-
Helt i tråd med deres tidligere udmeldelser de senere år.
-
Bortset fra en milestone som de overraskende medregnede - var det i 2015?
-
Ham på havnen? Han er SA-ekspert og giver fine maleriske SA-analyser som for det trænede øje og klare hjerne giver nogle formidable muligheder for at sprede sine investeringer så meget så muligt i Genmab som bøgerne foreskriver, du skal bare købe lidt af gangen til du er nået 100%. Pølsemanden hører til under Pro-investors Genmab-satire.
-
"Genmab's chief executive Jan van de Winkel has previously told Reuters he thinks Darzalex sales could surpass $10 billion a year if the drug is approved for a wider range of cancers." Is that true?? http://www.dailymail.co.uk/wires/reuters/article-4249900/Genmab-J-Js-cancer-drug-set-blockbuster-sales-year.html
-
yes, Twcie he told it in Q&As
-
their own calculations is showing better top sales than $8.7 billion
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind